carbamates and cyclin d1

carbamates has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, X; Cheng, W; Gong, P; Jiang, K; Li, Z; Lin, G; Liu, J; Meng, S; Piao, Y; Song, F; Song, Z; Zhao, Y; Zhu, X	1

Other Studies

1 other study(ies) available for carbamates and cyclin d1

Article	Year
Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells. Cancer letters, 2016, Jan-28, Volume: 370, Issue:2 Topics: Autophagy; Carbamates; Cell Line, Tumor; Cellular Senescence; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Dyrk Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; MAP Kinase Signaling System; Melanoma; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins B-raf; Retinoblastoma Protein; Sulfonamides; TOR Serine-Threonine Kinases	2016

Article

Year

Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells.

Cancer letters, 2016, Jan-28, Volume: 370, Issue:2

Topics: Autophagy; Carbamates; Cell Line, Tumor; Cellular Senescence; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Dyrk Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; MAP Kinase Signaling System; Melanoma; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins B-raf; Retinoblastoma Protein; Sulfonamides; TOR Serine-Threonine Kinases

2016